Bayer, J&J In The Frame For Bigger Anti-clotting Market Opportunity
Express Pharma|September 1-15, 2017

Their clot-prevention drug Xarelto could potentially be used on 30 million additional patients in its largest national markets once regulators give their go ahead for atherosclerosis indication.

Bayer, J&J In The Frame For Bigger Anti-clotting Market Opportunity

BAYER AND Johnson & Johnson’s blockbuster clot prevention drug Xarelto was shown to cut the risk of potentially deadly strokes and heart attacks in patients with severe atherosclerosis by 24 per cent, raising the prospects of billions more in sales.

Xarelto is already approved for a number of cardiovascular conditions and prevention of strokes caused by atrial fibrillation, a type of irregular heart beat common among the elderly, is the main profit driver.

Now the drug could potentially be used on 30 million additional patients in its largest national markets, once regulators give their go-ahead for the atherosclerosis indication, Bayer said. That would come on top of a population of roughly 25 million patients in atrial fibrillation.

In the irregular heart beat market, Xarelto is head to head with rival pill Eliquis, owned by Pfizer and Bristol-Myers Squibb, and also competes with Boehringer Ingelheim’s Pradaxa, but none of them have been tested in the atherosclerosis setting, mainly because of concerns over side effects.

Esta historia es de la edición September 1-15, 2017 de Express Pharma.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

Esta historia es de la edición September 1-15, 2017 de Express Pharma.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

MÁS HISTORIAS DE EXPRESS PHARMAVer todo
Blissfill-Calibrated syringe pipettes for repetitive laboratory dosing as per ISO 8655-9
Express Pharma

Blissfill-Calibrated syringe pipettes for repetitive laboratory dosing as per ISO 8655-9

Blissfill syringe pipettes provide laboratories with an ergonomic, self-refilling solution for repetitive dosing, delivering precise volumes from 0.05ml to 10ml. With ISO 8655-9 compliance and an included calibration certificate, Blissfill ensures accuracy and ease of use for high-demand lab applications

time-read
3 minutos  |
December 2024
Ensuring pharma compliance with testo data measurement technology
Express Pharma

Ensuring pharma compliance with testo data measurement technology

Comprehensive data measurement tools address regulatory demands and secure quality in pharma

time-read
4 minutos  |
December 2024
Waters launches software for lab-centric business intelligence enabling audit readiness
Express Pharma

Waters launches software for lab-centric business intelligence enabling audit readiness

waters_connect Data Intelligence software provides laboratories with comprehensive business intelligence on their chromatographic data throughout the product development lifecycle, enabling real-time audit readiness and query response, while reducing time spent on audit preparation

time-read
2 minutos  |
December 2024
Ensuring clean room integrity with Prime Clean Reset High-Speed Doors
Express Pharma

Ensuring clean room integrity with Prime Clean Reset High-Speed Doors

Designed with precision to meet the stringent requirements of controlled environments, Prime Clean Reset is the epitome of performance and reliability, ensuring that your clean room operations consistently meet the highest standards of regulatory compliance and product integrity

time-read
3 minutos  |
December 2024
Optimising efficiency with Remote Laboratory Solutions
Express Pharma

Optimising efficiency with Remote Laboratory Solutions

LabWare's comprehensive suite of software solutions designed specifically for laboratories offers reliable Remote Laboratory Solutions to help your business thrive in the current climate

time-read
1 min  |
December 2024
Ensuring water quality with the 6000TOCi: The ultimate solution for continuous TOC measurement
Express Pharma

Ensuring water quality with the 6000TOCi: The ultimate solution for continuous TOC measurement

The 6000TOCi Sensor is a comprehensive solution that brings together continuous monitoring, rapid response, reliability, and compliance

time-read
2 minutos  |
December 2024
Enhancing pharmaceutical analysis in critical areas
Express Pharma

Enhancing pharmaceutical analysis in critical areas

Dheeraj Handique, Manager GC/GCMS Product Marketing, Shimadzu Analytical (India) highlights the benefits of GCMS-TQ8050 NX with HS-20 NX trap for genotoxic impurities, nitrosamines, and, extractables and leachables

time-read
2 minutos  |
December 2024
Technical innovations for Annex 1
Express Pharma

Technical innovations for Annex 1

To meet the stringent EU GMP Annex 1 requirements, Optima presents innovative solutions to improve product and patient safety in pharmaceutical manufacturing. From minimising glove interventions and optimising First Air flow to advanced automation for integrity testing, this article explores how Optima's technologies support compliance in aseptic fill-and-finish processes

time-read
7 minutos  |
December 2024
JRS Pharma - The Global MCC Manufacturing Network
Express Pharma

JRS Pharma - The Global MCC Manufacturing Network

JRS Pharma is one of the largest manufacturers of MCC across the globe. The know-how is based on more than 25 years of experience in development of own processes

time-read
3 minutos  |
December 2024
Mack Pharmatech is the first to launch PLC-based environmental chambers in India
Express Pharma

Mack Pharmatech is the first to launch PLC-based environmental chambers in India

Manoj Choudhari, Managing Director, Mack Pharmatech shares insights on his company's pioneering expand globally and enhance regulatory compliance

time-read
3 minutos  |
December 2024